These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3450845)

  • 1. Concurrent intravenous administration of a labeled tracer to determine the oral bioavailability of a drug exhibiting Michaelis-Menten metabolism.
    Rubin GM; Waschek JA; Pond SM; Effeney DJ; Tozer TN
    J Pharmacokinet Biopharm; 1987 Dec; 15(6):615-31. PubMed ID: 3450845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theoretical considerations in the calculation of bioavailability of drugs exhibiting Michaelis-Menten elimination kinetics.
    Rubin GM; Tozer TN
    J Pharmacokinet Biopharm; 1984 Aug; 12(4):437-50. PubMed ID: 6527233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The assessment of bioavailability in the presence of nonlinear elimination.
    Hall SD; McAllister CB; Wilkinson GR
    J Pharmacokinet Biopharm; 1988 Jun; 16(3):263-78. PubMed ID: 3221326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic binding and Michaelis-Menten metabolism of drugs.
    Rubin GM; Tozer TN
    J Pharm Sci; 1986 Jul; 75(7):660-3. PubMed ID: 3761165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of hydroxyurea in cancer patients.
    Tracewell WG; Trump DL; Vaughan WP; Smith DC; Gwilt PR
    Cancer Chemother Pharmacol; 1995; 35(5):417-22. PubMed ID: 7850924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of drug kinetics in blood on the calculation of oral bioavailability in linear pharmacokinetics: the traditional equation may considerably overestimate the true value.
    Berezhkovskiy LM
    J Pharm Sci; 2006 Apr; 95(4):834-48. PubMed ID: 16493592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of the absolute bioavailability of rivastigmine in patients with mild to moderate dementia of the Alzheimer's type.
    Hossain M; Jhee SS; Shiovitz T; McDonald C; Sedek G; Pommier F; Cutler NR
    Clin Pharmacokinet; 2002; 41(3):225-34. PubMed ID: 11929322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ethanol drinking--absorption kinetics and first-pass effect.
    Fujimiya T; Fukui Y; Komura S
    Nihon Hoigaku Zasshi; 1995 Apr; 49(2):92-103. PubMed ID: 7783393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Input rate-dependent stereoselective pharmacokinetics: enantiomeric oral bioavailability and blood concentration ratios after constant oral input.
    Mehvar R
    Biopharm Drug Dispos; 1992 Nov; 13(8):597-615. PubMed ID: 1421053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipramine disposition in users of oral contraceptive steroids.
    Abernethy DR; Greenblatt DJ; Shader RI
    Clin Pharmacol Ther; 1984 Jun; 35(6):792-7. PubMed ID: 6734030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats.
    Egorin MJ; Yuan ZM; Sentz DL; Plaisance K; Eiseman JL
    Cancer Chemother Pharmacol; 1999; 43(6):445-53. PubMed ID: 10321503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of nitroglycerin after parenteral and oral dosing in the rat.
    Fung HL; Ogata H; Kamiya A; Maier GA
    J Pharm Sci; 1984 Jul; 73(7):873-9. PubMed ID: 6432996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saturable first-pass kinetics of propranolol.
    Keller F; Kunzendorf U; Walz G; Haller H; Offermann G
    J Clin Pharmacol; 1989 Mar; 29(3):240-5. PubMed ID: 2723110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma pharmacokinetics and bioavailability of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea after intravenous and oral administration to mice and dogs.
    Supko JG; Garcia-Carbonero R; Puchalski TA; Malspeis L
    Cancer Chemother Pharmacol; 2001 Sep; 48(3):202-8. PubMed ID: 11592341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.
    Chabot GG; Armand JP; Terret C; de Forni M; Abigerges D; Winograd B; Igwemezie L; Schacter L; Kaul S; Ropers J; Bonnay M
    J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics and bioavailability of a tracer dose of [3H]-mebendazole in man.
    Dawson M; Braithwaite PA; Roberts MS; Watson TR
    Br J Clin Pharmacol; 1985 Jan; 19(1):79-86. PubMed ID: 3978023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and bioavailability of methocarbamol in rats.
    Obach R; Pruñonosa J; Menargues A; Nomen M; Vallès J
    Biopharm Drug Dispos; 1988; 9(5):501-11. PubMed ID: 3224164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.